Cancer vaccines in the clinic and in trials
Most vaccines are given as prophylactics, agents that protect healthy individuals before exposure to a pathogen. By contrast, therapeutic...
GLP-1 receptor agonists and/or DPP4 inhibitors: Diabetes drugs may lower the risk of Parkinson’s disease
Parkinson’s disease, the most common neurodegenerative movement disorder has growing prevalence with the age. Due to increasing life expectancy...
COVID-19, Latest Stats, Strategies adopted by Italy, US & India : The Way Forward
The novel coronavirus (nCoV-19) or the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new public health crisis...
FDA grants accelerated approval to the first drug for Duchenne muscular dystrophy
The FDA has approved a new drug, Exondys 51, manufactured by Sarepta Therapeutics that targets exon 51 skipping. This...
Liraglutide demonstrated CV benefits among Diabetes Drugs
Liraglutide (Victoza®) is an injectable glucagon-like peptide-1 (GLP-1) receptor antagonist indicated in addition to diet and exercise to improve...